2 dagen gevuld met top sprekers rond het EK in Hasselt over de gezondheid en prestatie van wielrenners. Inschrijven via: hartcentrumhasselt.be/nl/w/cycling-m…

Echocardiography substudy of the STEP-#HFpEF Program shows #semaglutide improves adverse LA and RV remodeling compared with placebo in #obesity HFpEF: bit.ly/3XqCbV1 #JACC #ESCCongress

MVP Barlow disease! Don't know when we'll be able to post again, so... see ya #echofirst friends Benoy Shah MD Vladyslav Kavalerchyk 🇺🇦 Nicolas Merke Ritu Thamman MD Dr G Rajesh (Gopalan Nair Rajesh) Erik Rafflenbeul Raj Janardhanan, MD, MRCP, FACC, FASE Jan Verwerft Rodrigo G P Lima AG5-Kardiovaskulärer Ultraschall

#RESHAPE-HF2 Percutaneous repair of moderate-to-severe or severe functional mitral regurgitation in patients with symptomatic #heartfailure #ESCCongress #ESCHotlines #LBCT 📍 RCT: GDMT+device 🆚 GDMT alone 📍only 22% 💃🏻 (boo!) 📍⤵️ HF 🏥or CV☠️ in MVclip arm

Great debate: mechanical circulatory support in cardiogenic shock Navin Kapur vs Holger Thiele Dr Roxana Mehran Martine Gilard European Society of Cardiology

🔥RESHAPE-HF 2 published in NEJM met all 3 primary endpoints 📌 Median EROA 0.23, 56% grade 3+ MR 📌⬇️ 36% in CV death and HHF within 24 m 📌⬇️ 41% Recurrent HHF within 24 m 📌⬆️ 11 points KCCQ-OS 📌MitraClip in ⬇️ severe FMR needs further study nejm.org/doi/full/10.10…

Second T-TEER randomized trial: Tri-FR! Presented at #ESC2024 #ESCCongress2024 by Donal showing similar TRILUMINATE results: primary 1Yr endpoint driven by QoL but numerically lower mortality and HFH. Longer FU needed. European Society of Cardiology News European Society of Cardiology

European Society of Cardiology #ESCCongress PCRonline 🫀 NOTION 3 Trial @nejm 🔗nejm.org/doi/full/10.10… International trial w 1:1 randomization Patients w severe symptomatic AS & at least one coronary-artery stenosis + FFR of 0.80 or less or a diameter stenosis of at least 90% either to undergo

Today we presented the results of the RHEIA trial at ESC in London. This is the very first RCT transcatheter therapy that is dedicated to women. TAVR was superior to SAVR for the PE of mortality, stroke and rehospitalization.

#Aficamten 5/6 presentation In this innovative NT-proBNP/hs-troponin analysis (#SEQUOIA-HCM, afi vs placebo in oHCM) Caroline Coats and James Januzzi Jr MD show novel data on these biomarkers in obstructive #HCM Simultaneous pub in European Society of Cardiology Journals #ESCCongress #CardioTwitter

Mineralocorticoid Antagonism in Heart Failure: Established and Emerging Therapeutic Role Nonsteroidal MRAs show promise for HF due to superior specificity, potency, and tolerability jacc.org/doi/10.1016/j.…

Are you ready for another randomised trial on #diuretics in #heartfailure? The #DECONGEST trial has completed its recruitment, database has been locked and results will be presented soon... Proud to present our methods paper Journal of Cardiac Failure: onlinejcf.com/article/S1071-… Simon Vanhentenrijk

How to treat fluid OVERLOAD ? 🌊🚿💧💦 Must read tweetorial 👌 Is it better than standard of care? Stay tuned for 🇧🇪DECONGEST🇧🇪 results Heart Centre Hasselt|Jessa Ziekenhuis is proud to be part of it🫡 Thx TEAM Wouter L’Hoyes, Simon Vanhentenrijk and #Vincent_Vandoren

Our JACC editorial on the RESHAPE-HF2 trial: M-TEER in FMR-Erasing all doubt. RHF2 pts had lower EROA and ↑ LVEDV c/w COAPT (i.e. mostly mod FMR), w/substantially lower rates of mortality and HFH at 2 years. Nonetheless, HFH was markedly reduced and QOL was improved w/MitraClip.

Very important work on apical hypertrophy definitions to be incorporated in further guidelines. 15 mm at the apex is far thicker than at the base, and lack of thickness tapering at apex might as well signify apical HCM. Bravo RebeccaHughes, James moon and team!

ESC has come to an end. Below is a list with the simpub’s from the CTCPR Trials & CIRL team this year👇. Stay tuned, many more pubs soon! Nat Med: nature.com/articles/s4159… JACC: jacc.org/doi/10.1016/j.… JACC: jacc.org/doi/10.1016/j.… CircOut: ahajournals.org/doi/10.1161/CI… DOM: dom-pubs.onlinelibrary.wiley.com/doi/abs/10.111…

Now in JACC Journals #JACCHF, analysis ▶️ DAPA-HF+DELIVER ✅ Pts w/ recent HFH had highest clinical risk + greatest benefit post randomization for risk reduction of worsening HF + CV 💀 Pre-discharge implementation of #GDMT more important than ever tinyurl.com/4dr6y89p

Published today in JAMA Cardiology. Cardiopulmonary Exercise Testing (#CPET) in clinical trials captures ∆es in ex. performance. In #oHCM, aficamten ↑peak VO2, ↑workload, ↑cardiac power, ↑ VO2 at AT & improved ventilatory efficiency. Our novel z-score integrating ∆pVO2 and

‼️In case you missed the #ESCCongress session on strain evaluation in CRT 🚨Join us on the 4th of October for the Annual Congress of BWGNICI🫀 Subscription 👉 bwgnici.be 📍Belgium Jürgen Duchenne JUVoigt Caroline Van De Heyning Philippe Debonnaire Department of Cardiovascular Sciences - KU Leuven

💦🫁Lung water density is ⬆️ in patients at risk of heart 🫀failure and is largely independent of conventional #WhyCMR measures Our latest 🇦🇺paper out in #EHJIMP Led by Dr Nithin Iyer in collab w Calvin Chin in Singapore 🇸🇬and Rich Thompson in Edmonton 🇨🇦